Immunovant News and Activities

Presence

Immunovant develops antibody medicines for autoimmune diseases. Its main services include drug research and clinical development for hospitals, physicians, and patients who need new treatment options.

Immunovant products and services overview:

Antibody medicines
Autoimmune therapies
Drug research
Clinical development
Rare disease treatments

Revenue: ~$0 million

Employees: 160

Headquarters: New York, United States (USA)

Immunovant is owned by Sumitomo Chemical.

Sumitomo Chemical is one of the...

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 20 subsidiaries including Aetion, Aramis Biosciences and Asahi Chemical.

They are in:

Executives

View the org chart displaying its 31 main executives

Most searched biographies at Immunovant

Popular executive movements at Immunovant

Claudia Jacobs, Vice President, Chemistry, Manufacturing, and Controls Project Management, Operations and Global Supply Chain, has left the company (posted on April 16 2026).

Create your alert
to follow the executive moves at Immunovant.